Glenmark Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 23, 2025, recommended Final Dividend of Rs. 2.5 per equity share.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.9 pts less than Nifty Midcap 150 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Glenmark Pharmaceuticals' Board of Directors, at a meeting held on May 23, 2025, recommended a Final Dividend of Rs. 2.5 per equity share. This is a recommendation that will need shareholder approval before it is confirmed. The dividend will be paid to shareholders who hold the stock on the record date, which is expected to be announced separately. The final dividend amount suggests a modest payout consistent with the company's recent dividend history.
This is a routine dividend declaration that provides a small income to shareholders. Investors should watch for the record date announcement to be eligible for the payout, and check if it is in addition to any interim dividend already paid during the year.